Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

The Federal Circuit recently addressed a deceptively straightforward question: does a published U.S. patent application ...

Fisheye lenses are known for being both heavily distorted and literally heavy, but a recent patent application suggests that ...

Stablecoins have emerged as one of the most transformative innovations in the cryptocurrency space, bridging the gap between ...

Novacium innovative process uses Black Aluminum Dross as a feedstock to produce green hydrogen and transform the remaining ...

Howard Lutnick, the Wall Street executive in line to run the Commerce Department and champion tariffs in the Trump ...

Taylor Swift's legal team filed the final trademark registration extension for "Reputation (Taylor's Version)" and "Taylor ...

"Reliability and performance are at the core of our E-Motion™ powertrain systems," said Xavier Montagne, Chief Technology Officer at Vision Marine. "This patent application demonstrates the benefits ...

State Grid is the only utility company on the list. It's also the largest utility company in the world. Despite not being a technology company, it uses plenty of generative AI applications, including ...

Kristina Caggiano Kelly, David H. Holman and Lestin L. Kenton Jr. of Sterne, Kessler, Goldstein & Fox PLLC discuss a Federal ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile Ramat Gan, ...

The Utah Hockey Club's initial application for 'Utah Yetis' was rejected. But the franchise still has options.